Answers are grounded in this paper and cite their sources.
In this issue (pp. 305-310) Jun Ren and Amy J. Davidoff author an article entitled 'Alpha2-HS glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction'. The protein responsible for this biological activity has recently come to the forefront of research on the biological activity of plasma proteins.
No takes yet. Share an insight, caveat, or question.
Arnaúd et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: